BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3880372)

  • 21. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
    Gábor M
    Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
    Belcaro G; Rulo A; Candiani C
    Vasa; 1989; 18(2):146-51. PubMed ID: 2662674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of some semisynthetic rutoside derivatives on human platelets.
    Kahlé LH; Dannijs GJ; Ten Cate JW
    Bibl Anat; 1975; 13():263-4. PubMed ID: 1231745
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of troxerutin on platelet aggregation in patients with arteriosclerosis].
    Myśliwiec M; Bodzenta A
    Pol Tyg Lek; 1983 Oct; 38(44):1367-8. PubMed ID: 6674961
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of O-(beta-hydroxyethyl)-rutoside on wound healing in the rat.
    Wilhelmi G
    Pharmacology; 1979; 19(2):82-5. PubMed ID: 531085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Kinetic effect characterization of 0-beta-hydroxyethylrutoside (Venoruton) in healthy probands].
    Ott B; Rehn D; Nocker W; Diebschlag W
    Vasa Suppl; 1991; 33():218. PubMed ID: 1788678
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of troxerutin on the flow properties of blood under defined conditions of circulation. A double-blind study of patients with diabetic retinopathy and arteriosclerotic retinopathy].
    Gallasch G; Dörfer C; Schmitt T; Stage A
    Klin Monbl Augenheilkd; 1985 Jul; 187(1):30-5. PubMed ID: 3906246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of two venotropic drugs on inactivation and O-methylation of catecholamines in an isolated canine vein.
    Araújo D; Gulati O; Osswald W
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):192-202. PubMed ID: 4062437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Venoruton and capillary permeability].
    Cesarone MR; Laurora G; Gabini M; Errichi BM; Candiani C; Belcaro G
    Minerva Cardioangiol; 1989 May; 37(5):265-8. PubMed ID: 2779806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of O-(beta-hydroxyethyl)-rutoside on the glucose metabolism of cultured human varicose saphenous veins.
    Matagne D; Gilles R
    Arch Int Physiol Biochim; 1977 Feb; 85(1):133-8. PubMed ID: 68718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venoruton in the therapy of central retinal vein occlusion.
    Zygulska-Mach H; Kostka-Trabka E; Kielar J; Grodzinska L; Dieron K; Kedzior A
    Ther Hung; 1985; 33(2):79-82. PubMed ID: 3842005
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
    Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
    Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the haemolytic action of amphiphilic substances in vitro. Inhibition by O-(beta-hydroxyethyl)-rutosides.
    Biesendorfer H; Felix W; Wildenauer DB
    Biochem Pharmacol; 1981 Aug; 30(16):2287-92. PubMed ID: 7295341
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of Venoruton on the lower-leg volume in normal persons and in patients with venous-flow disorders].
    Bopp J
    Med Welt; 1977 Oct; 28(41):1660-4. PubMed ID: 927128
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of sudden deafness of vascular etiology with venoruton].
    Madej S
    Otolaryngol Pol; 1989; 43(3):214-7. PubMed ID: 2695884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
    Forconi S; Guerrini M
    Clin Ter; 1977 Feb; 80(3):229-55. PubMed ID: 852233
    [No Abstract]   [Full Text] [Related]  

  • 37. Analgesic effect of O-(beta-hydroxy ethyl)rutoside in mice.
    Ramaswamy S; Pillai NP; Gopalakrishnan V; Parmar NS; Ghosh MN
    Indian J Exp Biol; 1985 Apr; 23(4):219-20. PubMed ID: 4077117
    [No Abstract]   [Full Text] [Related]  

  • 38. Spectrophotofluorometric analysis of 3',4',7-tris[O-(beta-hydroxyethyl)]rutoside in urine.
    Tan HS; Mowery PJ; Ritschel WA; Neu C
    J Pharm Sci; 1978 Aug; 67(8):1142-4. PubMed ID: 671254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
    Piller NB; Morgan RG; Casley-Smith JR
    Br J Plast Surg; 1988 Jan; 41(1):20-7. PubMed ID: 3278764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacolymphography with Venalot and Venoruton--a 7 years' report].
    Schmidt F; Keilacker M
    Radiol Diagn (Berl); 1985; 26(1):41-51. PubMed ID: 3991896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.